BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24673663)

  • 1. Observational study on the mitotic rate and other prognostic factors in cutaneous primary melanoma arising from naevi and from melanoma de novo.
    Betti R; Santambrogio R; Cerri A; Vergani R; Moneghini L; Menni S
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1738-41. PubMed ID: 24673663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanomas arising from naevi and de novo melanomas--does origin matter?
    Weatherhead SC; Haniffa M; Lawrence CM
    Br J Dermatol; 2007 Jan; 156(1):72-6. PubMed ID: 17199569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
    Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
    J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevus-associated melanomas: clinicopathologic features.
    Shitara D; Nascimento MM; Puig S; Yamada S; Enokihara MM; Michalany N; Bagatin E
    Am J Clin Pathol; 2014 Oct; 142(4):485-91. PubMed ID: 25239415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous melanoma associated with previous nevus].
    Gutiérrez MP; Barengo M; Mainardi C; Garay I; Kurpis M; Ruiz Lascano A
    Medicina (B Aires); 2009; 69(5):536-40. PubMed ID: 19897439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial association of melanocytic naevus and melanoma.
    Urso C; Giannotti V; Reali UM; Giannotti B; Bondi R
    Melanoma Res; 1991; 1(4):245-9. PubMed ID: 1823633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
    Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
    Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study.
    Savoia P; Osella-Abate S; Deboli T; Marenco F; Stroppiana E; Novelli M; Fierro MT; Bernengo MG
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):882-8. PubMed ID: 21819449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of sentinel lymph node biopsy in melanomas of different Breslow's thickness.
    Seyed Jafari SM; Jäckle P; Michel A; Angermeier S; Hunger R; Shafighi M
    Swiss Med Wkly; 2016; 146():w14358. PubMed ID: 27684508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De Novo and Nevus-Associated Melanomas: Different Histopathologic Characteristics but Similar Survival Rates.
    Tas F; Erturk K
    Pathol Oncol Res; 2020 Oct; 26(4):2483-2487. PubMed ID: 32572820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.
    Kaddu S; Smolle J; Zenahlik P; Hofmann-Wellenhof R; Kerl H
    Melanoma Res; 2002 Jun; 12(3):271-8. PubMed ID: 12140384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with de novo versus nevus-associated melanoma.
    Lin WM; Luo S; Muzikansky A; Lobo AZ; Tanabe KK; Sober AJ; Cosimi AB; Tsao H; Duncan LM
    J Am Acad Dermatol; 2015 Jan; 72(1):54-8. PubMed ID: 25440436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus.
    Pan Y; Adler NR; Wolfe R; McLean CA; Kelly JW
    Med J Aust; 2017 Oct; 207(8):333-338. PubMed ID: 29020904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological, Genetic and Survival Advantages of Naevus-associated Melanomas: A Cohort Study.
    Bosch-Amate X; Podlipnik S; Riquelme-Mc Loughlin C; Carrera C; Barreiro-Capurro A; García-Herrera A; Alós L; Malvehy J; Puig S
    Acta Derm Venereol; 2021 Mar; 101(3):adv00425. PubMed ID: 33686449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naevus-associated melanomas: cause or chance?
    Massi D; Carli P; Franchi A; Santucci M
    Melanoma Res; 1999 Feb; 9(1):85-91. PubMed ID: 10338338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
    Stadler R; Garbe C
    Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational cross-sectional study comparing Breslow thickness of melanoma arising from naevi and melanoma de novo.
    Garcia-Cruz A; Flórez A; de la Torre-Fraga C; Cruces Prado M
    Br J Dermatol; 2009 Sep; 161(3):700-2. PubMed ID: 19575730
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between tumor size and Breslow's thickness in malignant melanoma: a cross-sectional, multicenter study.
    Moreno-Ramírez D; Ojeda-Vila T; Ríos-Martín JJ; Nieto-García A; Ferrándiz L
    Melanoma Res; 2015 Oct; 25(5):450-2. PubMed ID: 26237766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do all melanomas come from "moles"? A study of the histological association between melanocytic naevi and melanoma.
    Marks R; Dorevitch AP; Mason G
    Australas J Dermatol; 1990; 31(2):77-80. PubMed ID: 2095738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplastic vs. Common Naevus-associated vs. De novo Melanomas: An Observational Retrospective Study of 1,021 Patients.
    Martin-Gorgojo A; Requena C; Garcia-Casado Z; Traves V; Kumar R; Nagore E
    Acta Derm Venereol; 2018 Jun; 98(6):556-562. PubMed ID: 29583157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.